NewSquare Capital’s Repligen RGEN Stock Holding History

NewSquare Capital’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-16	Closed	-$1.99K	–	990
2025 Q2	$1.99K	Buy	16 +14	+700%	+$1.78K	﹤0.01%	967
2025 Q1	$254	Buy	+2	New	+$308	﹤0.01%	1099
2023 Q3	–	Sell	-6	Closed	-$849	–	833
2023 Q2	$849	Sell	6 -501	-99%	-$80.3K	﹤0.01%	627
2023 Q1	$85.4K	Hold	507	–	–	0.01%	172
2022 Q4	$85.8K	Buy	507 +2	+0.4%	+$363	0.01%	162
2022 Q3	$94K	Hold	505	–	–	0.01%	160
2022 Q2	$82K	Buy	505 +500	+10,000%	+$79.1K	0.01%	173
2022 Q1	$1K	Sell	5 -1	-17%	-$190	﹤0.01%	366
2021 Q4	$2K	Hold	6	–	–	﹤0.01%	350
2021 Q3	$2K	Hold	6	–	–	﹤0.01%	339
2021 Q2	$1K	Hold	6	–	–	﹤0.01%	338
2021 Q1	$1K	Buy	+6	New	+$1.23K	﹤0.01%	317
2020 Q1	–	Sell	-6,925	Closed	-$641K	–	388
2019 Q4	$641K	Buy	+6,925	New	+$582K	0.11%	98

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

NewSquare Capital's RGEN Position: Q3 2025 in Review

NewSquare Capital sold out of Repligen (RGEN) in Q3 2025, closing a stake of 16 shares — an estimated $1.99K sold.

NewSquare Capital first reported a position in RGEN in Q4 2019 and held it in 13 quarters. The position peaked at $641K in Q4 2019. 453 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

NewSquare Capital reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
NewSquare Capital sold 16 Repligen shares in Q3 2025, an estimated $1.99K.
NewSquare Capital first reported a position in Repligen in Q4 2019 and held it in 13 quarters.
NewSquare Capital's Repligen position peaked at $641K in Q4 2019.
453 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on NewSquare Capital's 13F filing for Q3 2025, filed 12 Nov 2025.